DK0759919T3 - Azolidindioner som antihyperglykæmiske midler - Google Patents

Azolidindioner som antihyperglykæmiske midler

Info

Publication number
DK0759919T3
DK0759919T3 DK95916989T DK95916989T DK0759919T3 DK 0759919 T3 DK0759919 T3 DK 0759919T3 DK 95916989 T DK95916989 T DK 95916989T DK 95916989 T DK95916989 T DK 95916989T DK 0759919 T3 DK0759919 T3 DK 0759919T3
Authority
DK
Denmark
Prior art keywords
image
azolidinediones
antihyperglycemic agents
alkyl
antihyperglycemic
Prior art date
Application number
DK95916989T
Other languages
Danish (da)
English (en)
Inventor
Michael Sotiorios Malamas
Iwan Gunawan
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of DK0759919T3 publication Critical patent/DK0759919T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44Two oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Indole Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
DK95916989T 1994-05-18 1995-04-13 Azolidindioner som antihyperglykæmiske midler DK0759919T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/245,734 US5468762A (en) 1994-05-18 1994-05-18 Azolidinediones as antihyperglycemic agents
PCT/US1995/004631 WO1995031454A1 (en) 1994-05-18 1995-04-13 New azolidinediones as antihyperglycemic agents

Publications (1)

Publication Number Publication Date
DK0759919T3 true DK0759919T3 (da) 1999-07-26

Family

ID=22927868

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95916989T DK0759919T3 (da) 1994-05-18 1995-04-13 Azolidindioner som antihyperglykæmiske midler

Country Status (17)

Country Link
US (2) US5468762A (de)
EP (1) EP0759919B1 (de)
JP (1) JPH10500133A (de)
KR (1) KR970703340A (de)
CN (1) CN1152312A (de)
AT (1) ATE173256T1 (de)
AU (1) AU684357B2 (de)
CA (1) CA2190015A1 (de)
DE (1) DE69505968T2 (de)
DK (1) DK0759919T3 (de)
ES (1) ES2124545T3 (de)
GR (1) GR3029355T3 (de)
HU (1) HUT76823A (de)
NZ (1) NZ284654A (de)
TW (1) TW328089B (de)
WO (1) WO1995031454A1 (de)
ZA (1) ZA953981B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69418311T2 (de) * 1993-12-27 1999-11-04 Japan Tobacco Inc., Tokio/Tokyo Isoxazolidindionderivate und deren verwendung
ATE235476T1 (de) * 1994-08-10 2003-04-15 Takeda Chemical Industries Ltd Thiazolidindione derivate, ihre herstellung und verwendung
TW403748B (en) * 1994-11-02 2000-09-01 Takeda Chemical Industries Ltd An oxazolidinedione derivative, its production and a pharmaceutical composition for lowering blood sugar and lipid in blood comprising the same
CA2171702A1 (en) * 1995-03-14 1996-09-15 Takashi Sohda Benzofuran compounds and their use
US5925656A (en) * 1995-04-10 1999-07-20 Dr. Reddy's Research Foundation Compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
ZA973850B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel antidiabetic compounds having hypolipidaemic, anti-hypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5889032A (en) * 1996-05-06 1999-03-30 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US6114526A (en) 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US5985884A (en) * 1996-07-01 1999-11-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6372750B2 (en) * 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
US6313113B1 (en) * 1997-04-15 2001-11-06 Reddy-Cheminor, Inc. Heterocyclic compounds having antidiabetic, hypolipidemic and antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US6011031A (en) * 1997-05-30 2000-01-04 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension: process for their preparation and pharmaceutical compositions containing them
AU6331199A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Oxazolidine derivatives for the treatment and prevention of metabolic bone disorders
US6756360B1 (en) 1998-12-24 2004-06-29 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
AU6875800A (en) * 1999-09-10 2001-04-17 Takeda Chemical Industries Ltd. Heterocyclic compounds and process for the preparation thereof
SK8892002A3 (en) * 1999-12-22 2003-04-01 Metabasis Therapeutics Inc Novel bisamidate phosphonate prodrugs, process for their preparation and use thereof
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
EP1442028A4 (de) * 2001-11-06 2009-11-04 Bristol Myers Squibb Co Substituierte säurederivate, die sich als antidiabetika und mittel gegen obesitas eignen, und verfahren
US7148246B2 (en) * 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
US7141592B2 (en) * 2003-09-25 2006-11-28 Wyeth Substituted oxadiazolidinediones
US7351726B2 (en) * 2003-09-25 2008-04-01 Wyeth Substituted oxadiazolidinediones
BRPI0514372A (pt) * 2004-08-18 2008-06-10 Metabasis Therapeutics Inc inibidores de tiazol de frutose 1, 6-bisfosfatase
US9623015B2 (en) 2012-11-05 2017-04-18 Commissariat À L'energie Atomique Et Aux Energies Alternatives (Cea) Combination of an anti-cancer agent such as a tyrosinekinase inhibitor and a STAT5 antagonist, preferably a thiazolidinedione, for eliminating hematologic cancer stem cells in vivo and for preventing hematologic cancer relapse

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
ES2067945T3 (es) * 1990-08-23 1995-04-01 Pfizer Derivados de hidroxiurea hipoglicemica.
FR2673427B1 (fr) * 1991-03-01 1993-06-18 Sanofi Elf Derives heterocycliques diazotes n-substitues par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant.
TW268952B (de) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
WO1995031454A1 (en) 1995-11-23
US5510360A (en) 1996-04-23
DE69505968D1 (de) 1998-12-17
NZ284654A (en) 1998-12-23
CN1152312A (zh) 1997-06-18
CA2190015A1 (en) 1995-11-23
EP0759919B1 (de) 1998-11-11
KR970703340A (ko) 1997-07-03
JPH10500133A (ja) 1998-01-06
HUT76823A (en) 1997-11-28
ATE173256T1 (de) 1998-11-15
US5468762A (en) 1995-11-21
AU684357B2 (en) 1997-12-11
DE69505968T2 (de) 1999-05-12
EP0759919A1 (de) 1997-03-05
ES2124545T3 (es) 1999-02-01
TW328089B (en) 1998-03-11
AU2384295A (en) 1995-12-05
GR3029355T3 (en) 1999-05-28
HU9603185D0 (en) 1997-01-28
ZA953981B (en) 1996-11-18

Similar Documents

Publication Publication Date Title
DK0759919T3 (da) Azolidindioner som antihyperglykæmiske midler
KR950701911A (ko) 피페리딘 유도체를 유효성분으로 하는 말초혈관확장제(peripheral vaso-dilating agent containing piperidine derivative as active ingredient)
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
WO2003016291A1 (fr) Activateur du recepteur $g(d) sensible au proliferateur de peroxysome
NO980817D0 (no) Meta-guanidin-, urea-, tiourea- eller azacykliske aminobenzosyrederivater som integrin-antagonister
CA2113229A1 (en) Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
MX9602837A (es) Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados.
DK0628311T3 (da) Xanthinderivater som antidepressive midler
GB9408185D0 (en) New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
EP0632031A4 (de)
ES2191341T3 (es) Derivados de la 2-fenoxianilina.
DK0553016T3 (da) Hidtil ukendte naphtalenamider og -sulfonamider, fremgangsmåder til deres fremstilling samt farmaceutiske midler indeholdende dem
FI956151A0 (fi) Iskeemisissä taudeissa käyttökelpoisia bentseenijohdannaisia
EP0552489A3 (de)
DK0420224T3 (da) Anthihepatopatisk middel
ES2058458T3 (es) Inhibidor de la formacion de la placa dental.
EP0987257A4 (de) 1,2,3-thiadiazol-derivate, mittel zur kontrolle von pflanzenkrankheiten und methode zu seiner anwendung
EP0982029A4 (de) Vorbeugende /heilmittel fuer arteriosklerose
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
ECSP951498A (es) Nuevos derivados de pirrocarbazol case ran 4121/15
EP1241166A4 (de) 3-mehtyl-chroman und -thiochromanderivate
TW360630B (en) A secoaporphine compounds on arrhythmia
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.